Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway

Annalisa Lonetti, Francesca Chiarini|Journal of Hematology & Oncology|2016

Cited by 62